Changing open heart surgery forever with Edwards Lifesciences CEO Michael Mussallem

Changing open heart surgery forever with Edwards Lifesciences CEO Michael Mussallem
DeviceTalks Podcast Network
Changing open heart surgery forever with Edwards Lifesciences CEO Michael Mussallem

Jun 06 2013 | 00:23:19

/
Episode • June 06, 2013 • 00:23:19

Hosted By

Kayleen Brown Tom Salemi

Show Notes

After a stellar 2010, Michael Mussallem, CEO of Edwards Lifesciences Corp., is feeling bullish on transcatheter heart valves and the future of the Irvine, Calif.-based cardiac device maker.

Previous Episode

Inside Abiomed and GI Dynamics with CEOs Mike Minogue and Stu Randle

Next Episode

How we made an artificial nervous system with Alfred Mann Foundation CEO David Hankin

Other Episodes

November 25, 2022

Intuitive CEO Guthart shares views on ION ablation, rising competition and robotic surgery’s future

This episode of IntuitiveTalks is taken from the keynote interview Intuitive CEO Gary Guthart gave at DeviceTalks West. In this conversation Guthart will provide...

Play

00:45:11

May 26, 2023

How Anika Therapeutics is using M&A and R&D to evolve into a global joint preservation business

In this episode, Cheryl R. Blanchard, Ph.D., CEO of Anika Therapeutics, explains how the company is morphing from a biomaterials into a joint preservation...

Play

00:56:02

August 01, 2025

J&J Vision’s Menziuso sees huge opportunity; Boston Scientific’s view of AI-driven Diagnostics

In this episode of the DeviceTalks Weekly podcast, MassDevice Editor Chris Newmarker speaks with Peter Menziuso, Johnson & Johnson company group chair for Vision,...

Play

01:10:21